LOCALIZED CUTANEOUS LEISHMANIASIS

Clinical trials for LOCALIZED CUTANEOUS LEISHMANIASIS explained in plain language.

Never miss a new study

Get alerted when new LOCALIZED CUTANEOUS LEISHMANIASIS trials appear

Sign up with your email to follow new studies for LOCALIZED CUTANEOUS LEISHMANIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New pill could cure disfiguring skin disease in months

⭐️ CURE ⭐️ Not yet recruiting

This study tests two different doses of an experimental oral drug, LXE408, against a standard treatment (miltefosine) for localized cutaneous leishmaniasis, a parasitic skin infection. About 250 adults with up to six skin sores will receive one of the treatments for several weeks…

Matched conditions: LOCALIZED CUTANEOUS LEISHMANIASIS

Phase: PHASE2 • Sponsor: Drugs for Neglected Diseases • Aim: ⭐️ CURE ⭐️

Last updated May 09, 2026 05:34 UTC

LOCALIZED CUTANEOUS LEISHMANIASIS

Get alerted when new LOCALIZED CUTANEOUS LEISHMANIASIS trials appear

New pill could cure disfiguring skin disease in months